Your browser doesn't support javascript.
loading
Genome-wide analyses reveal novel opioid use disorder loci and genetic overlap with schizophrenia, bipolar disorder, and major depression.
Holen, Børge; Shadrin, Alexey A; Icick, Romain; Filiz, Tahir T; Hindley, Guy; Rødevand, Linn; O'Connell, Kevin S; Hagen, Espen; Frei, Oleksandr; Bahrami, Shahram; Cheng, Weiqiu; Parker, Nadine; Tesfaye, Markos; Jaholkowski, Piotr; Karadag, Naz; Dale, Anders M; Djurovic, Srdjan; Smeland, Olav B; Andreassen, Ole A.
Afiliación
  • Holen B; NORMENT, Institute of Clinical Medicine, Division of Mental Health and Addiction, Oslo University Hospital, University of Oslo, Oslo, Norway.
  • Shadrin AA; NORMENT, Institute of Clinical Medicine, Division of Mental Health and Addiction, Oslo University Hospital, University of Oslo, Oslo, Norway.
  • Icick R; NORMENT, Institute of Clinical Medicine, Division of Mental Health and Addiction, Oslo University Hospital, University of Oslo, Oslo, Norway.
  • Filiz TT; INSERM UMR-S1144, Paris University, Paris, France.
  • Hindley G; NORMENT, Institute of Clinical Medicine, Division of Mental Health and Addiction, Oslo University Hospital, University of Oslo, Oslo, Norway.
  • Rødevand L; NORMENT, Institute of Clinical Medicine, Division of Mental Health and Addiction, Oslo University Hospital, University of Oslo, Oslo, Norway.
  • O'Connell KS; NORMENT, Institute of Clinical Medicine, Division of Mental Health and Addiction, Oslo University Hospital, University of Oslo, Oslo, Norway.
  • Hagen E; NORMENT, Institute of Clinical Medicine, Division of Mental Health and Addiction, Oslo University Hospital, University of Oslo, Oslo, Norway.
  • Frei O; NORMENT, Institute of Clinical Medicine, Division of Mental Health and Addiction, Oslo University Hospital, University of Oslo, Oslo, Norway.
  • Bahrami S; NORMENT, Institute of Clinical Medicine, Division of Mental Health and Addiction, Oslo University Hospital, University of Oslo, Oslo, Norway.
  • Cheng W; NORMENT, Institute of Clinical Medicine, Division of Mental Health and Addiction, Oslo University Hospital, University of Oslo, Oslo, Norway.
  • Parker N; NORMENT, Institute of Clinical Medicine, Division of Mental Health and Addiction, Oslo University Hospital, University of Oslo, Oslo, Norway.
  • Tesfaye M; NORMENT, Institute of Clinical Medicine, Division of Mental Health and Addiction, Oslo University Hospital, University of Oslo, Oslo, Norway.
  • Jaholkowski P; NORMENT, Institute of Clinical Medicine, Division of Mental Health and Addiction, Oslo University Hospital, University of Oslo, Oslo, Norway.
  • Karadag N; NORMENT, Institute of Clinical Medicine, Division of Mental Health and Addiction, Oslo University Hospital, University of Oslo, Oslo, Norway.
  • Dale AM; NORMENT, Institute of Clinical Medicine, Division of Mental Health and Addiction, Oslo University Hospital, University of Oslo, Oslo, Norway.
  • Djurovic S; Department of Cognitive Science, University of California San Diego, La Jolla, California, USA.
  • Smeland OB; Department of Radiology, University of California San Diego, La Jolla, California, USA.
  • Andreassen OA; Multimodal Imaging Laboratory, University of California San Diego, La Jolla, California, USA.
Addict Biol ; 28(6): e13282, 2023 06.
Article en En | MEDLINE | ID: mdl-37252880

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Esquizofrenia / Trastorno Bipolar / Trastorno Depresivo Mayor Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Addict Biol Asunto de la revista: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Año: 2023 Tipo del documento: Article País de afiliación: Noruega

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Esquizofrenia / Trastorno Bipolar / Trastorno Depresivo Mayor Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Addict Biol Asunto de la revista: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Año: 2023 Tipo del documento: Article País de afiliación: Noruega